TrialJournal of gastroenterology2014

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis.

Yasuo Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.